Mounjaro KwikPen

Description

The Mounjaro KwikPen is a once-weekly injectable medication that contains tirzepatide, used for managing type 2 diabetes in adults alongside diet and exercise. It works by activating two hormone pathways—GLP-1 and GIP—to increase insulin production when blood sugar is high, reduce sugar production in the liver, and slow digestion, all of which help lower blood glucose levels effectively. The pen device delivers precise doses of Mounjaro to support consistent treatment and improved blood sugar control.

Mounjaro is prescribed for adults whose type 2 diabetes is not adequately controlled by other treatments or who cannot take metformin. Besides lowering blood sugar and HbA1c, treatment with Mounjaro can also support weight loss and improve other factors like blood pressure and fat levels in the blood. The KwikPen is designed for easy self-administration under the skin and helps patients maintain better management of their diabetes through a convenient, once-weekly dosing schedule.